Organogenesis Holdings (ORGO) Consolidated Net Income: 2016-2024
Historic Consolidated Net Income for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -$9.9 million.
- Organogenesis Holdings' Consolidated Net Income rose 74.90% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 31.63%. This contributed to the annual value of -$9.9 million for FY2024, which is 299.35% down from last year.
- According to the latest figures from FY2024, Organogenesis Holdings' Consolidated Net Income is -$9.9 million, which was down 299.35% from $4.9 million recorded in FY2023.
- In the past 5 years, Organogenesis Holdings' Consolidated Net Income registered a high of $94.2 million during FY2021, and its lowest value of -$9.9 million during FY2024.
- In the last 3 years, Organogenesis Holdings' Consolidated Net Income had a median value of $4.9 million in 2023 and averaged $3.5 million.
- Its Consolidated Net Income has fluctuated over the past 5 years, first soared by 446.61% in 2021, then crashed by 299.35% in 2024.
- Organogenesis Holdings' Consolidated Net Income (MRY) stood at $17.2 million in 2020, then soared by 446.61% to $94.2 million in 2021, then tumbled by 83.51% to $15.5 million in 2022, then crashed by 68.16% to $4.9 million in 2023, then crashed by 299.35% to -$9.9 million in 2024.
- Its last three reported values are -$9.9 million in FY2024, $4.9 million for FY2023, and $15.5 million during FY2022.